Cargando…

Clinical and reproductive outcomes of fertility-sparing surgery in stage I epithelial ovarian cancer

The aim of the present study was to evaluate the oncologic safety and reproductive outcome in patients with stage I epithelial ovarian cancer (EOC) treated with fertility-sparing surgery (FSS). Women aged ≤40 years with stage I EOC who had undergone FSS between 2000 and 2010 were retrospectively rev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watanabe, Takafumi, Soeda, Shu, Nishiyama, Hiroshi, Kiko, Yuichiroh, Tokunaga, Hideki, Shigeta, Shogo, Yaegashi, Nobuo, Yamada, Hidekazu, Ohta, Tsuyoshi, Nagase, Satoru, Shoji, Tadahiro, Kagabu, Masahiro, Baba, Tsukasa, Shimizu, Dai, Sato, Naoki, Terada, Yukihiro, Futagami, Masayuki, Yokoyama, Yoshihito, Fujimori, Keiya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904870/ https://www.ncbi.nlm.nih.gov/pubmed/31832189 http://dx.doi.org/10.3892/mco.2019.1954

Ejemplares similares

A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)
por: Shoji, Tadahiro, et al.
Publicado: (2017)

Successful laparoscopic resection of ovarian abscess caused by Staphylococcus aureus in a 13-year-old girl: a case report and review of literature
por: Murata, Tsuyoshi, et al.
Publicado: (2021)

The measurement of stiffness of uterine smooth muscle tumor by elastography
por: Furukawa, Shigenori, et al.
Publicado: (2014)

Metabolomic analysis of uterine serous carcinoma with acquired resistance to paclitaxel
por: Seino, Manabu, et al.
Publicado: (2018)

Correction: Metabolomic analysis of uterine serous carcinoma with acquired resistance to paclitaxel
por: Seino, Manabu, et al.
Publicado: (2021)

Production of IL1-beta by ovarian cancer cells induces mesothelial cell beta1-integrin expression facilitating peritoneal dissemination
por: Watanabe, Takafumi, et al.
Publicado: (2012)

A phase I study of irinotecan and pegylated liposomal doxorubicin in recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)
por: Shoji, Tadahiro, et al.
Publicado: (2014)

Serum levels of rapid turnover proteins are decreased and related to systemic inflammation in patients with ovarian cancer
por: WATANABE, TAKAFUMI, et al.
Publicado: (2014)

A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study)
por: Nagasawa, Takayuki, et al.
Publicado: (2023)

Liquid biopsy with droplet digital PCR targeted to specific mutations in plasma cell-free tumor DNA can detect ovarian cancer recurrence earlier than CA125
por: Minato, Takamichi, et al.
Publicado: (2021)

Potential of Tyrosine Kinase Receptor TIE-1 as Novel Therapeutic Target in High-PI3K-Expressing Ovarian Cancer
por: Zhang, Xuewei, et al.
Publicado: (2020)

Immunotherapy for Uterine Cervical Cancer
por: Kagabu, Masahiro, et al.
Publicado: (2019)

Sclerosing stromal tumor of the ovary treated with 2-incision total laparoscopic cystectomy
por: Furukawa, Shigenori, et al.
Publicado: (2015)

CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents
por: Oyama, Yoshiko, et al.
Publicado: (2021)

Mild phenotypes associated with an unbalanced X‐autosome translocation, 46,X,der(X)t(X;8)(q28;q13)
por: Watanabe, Takafumi, et al.
Publicado: (2018)

Expectations and Challenges of First-Line Maintenance Therapy for Advanced Ovarian Cancer
por: Shoji, Tadahiro, et al.
Publicado: (2021)

The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guidelines evaluation committee
por: Ikeda, Masae, et al.
Publicado: (2021)

Diagnostic Performance of Preoperative Imaging in Endometrial Cancer
por: Hashimoto, Chiaki, et al.
Publicado: (2023)

Rare Hereditary Gynecological Cancer Syndromes
por: Watanabe, Takafumi, et al.
Publicado: (2022)

Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions
por: Kagabu, Masahiro, et al.
Publicado: (2020)

Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study
por: Kagabu, Masahiro, et al.
Publicado: (2021)

Prediction of lymphovascular space invasion in endometrial cancer using the 55-gene signature selected by DNA microarray analysis
por: Watanabe, Takafumi, et al.
Publicado: (2019)

Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer
por: Kojima, Manabu, et al.
Publicado: (2020)

Addendum: Manabu, K., et al. Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers 2020, 12, 2748
por: Kojima, Manabu, et al.
Publicado: (2021)

Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas
por: Shoji, Tadahiro, et al.
Publicado: (2021)

Assessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: a project of the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committee
por: Shigeta, Shogo, et al.
Publicado: (2017)

A case of a woman with late-pregnancy-onset DKA who had normal glucose tolerance in the first trimester
por: Himuro, Hiromi, et al.
Publicado: (2014)

A New Therapeutic Strategy for Recurrent Ovarian Cancer―Bevacizumab beyond Progressive Disease
por: Shoji, Tadahiro, et al.
Publicado: (2019)

Successful pregnancy and term delivery after treatment of unicornuate uterus with non-communicating rudimentary horn pregnancy with local methotrexate injection followed by laparoscopic resection: a case report and literature review
por: Ueda, Makiko, et al.
Publicado: (2021)

Precautions during Direct Oral Anticoagulant Introduction in Gynecologic Malignancies: A Single-Center Retrospective Cohort Study
por: Shimizu, Takanori, et al.
Publicado: (2023)

Novel cooperative pathway of c-Myc and Furin, a pro-protein convertase, in cell proliferation as a therapeutic target in ovarian cancers
por: Hasegawa-Minato, Junko, et al.
Publicado: (2017)

Synchronous bilateral primary ovarian cancer with right endometroid carcinoma and left high-grade serous carcinoma: a case report and literature review
por: Fujimori, Mimori, et al.
Publicado: (2022)

Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review
por: Murakami, Isao, et al.
Publicado: (2023)

Reduced Claudin-12 Expression Predicts Poor Prognosis in Cervical Cancer
por: Rahman, Abidur, et al.
Publicado: (2021)

Total Laparoscopic Conservative Surgery for an Intramural Ectopic Pregnancy
por: Nabeshima, Hiroshi, et al.
Publicado: (2010)

Ceramide limits phosphatidylinositol-3-kinase C2β-controlled cell motility in ovarian cancer: potential of ceramide as a metastasis-suppressor lipid
por: Kitatani, Kazuyuki, et al.
Publicado: (2015)

Prenatal diagnosis of fetal microhydranencephaly: a case report and literature review
por: Omoto, Takahiro, et al.
Publicado: (2020)

Clinical implication of oncogenic somatic mutations in early-stage cervical cancer with radical hysterectomy
por: Watanabe, Takafumi, et al.
Publicado: (2020)

Successful pregnancy and delivery after a vitrified-warmed embryo transfer in a woman with Kallmann syndrome: A case report and literature review
por: Shiraiwa, Aya, et al.
Publicado: (2022)

Clinical relevance of oncogenic driver mutations identified in endometrial carcinoma
por: Watanabe, Takafumi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d72cs466colfgrr43ftqknrili